Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABCZF OTCMKTS:ATTBF OTCMKTS:FFNTF OTCMKTS:QBIO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABCZFAbcamC$22.25C$22.25C$5.00▼C$23.80N/AN/A2,659 shsN/AATTBFAbattis Bioceuticals$0.00$0.00▼$0.00N/AN/A11,650 shsN/AFFNTF4Front Ventures$0.00$0.00▼$0.07N/AN/A1.28 million shs400 shsQBIOQ Biomed$0.00$0.00▼$0.03N/AN/AN/AN/A10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABCZFAbcam0.00%0.00%0.00%0.00%0.00%ATTBFAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%FFNTF4Front Ventures0.00%0.00%0.00%0.00%-93.75%QBIOQ Biomed0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABCZFAbcamC$22.25C$22.25C$5.00▼C$23.80N/AN/A2,659 shsN/AATTBFAbattis Bioceuticals$0.00$0.00▼$0.00N/AN/A11,650 shsN/AFFNTF4Front Ventures$0.00$0.00▼$0.07N/AN/A1.28 million shs400 shsQBIOQ Biomed$0.00$0.00▼$0.03N/AN/AN/AN/A10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABCZFAbcam0.00%0.00%0.00%0.00%0.00%ATTBFAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%FFNTF4Front Ventures0.00%0.00%0.00%0.00%-93.75%QBIOQ Biomed0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABCZFAbcam 0.00N/AN/AN/AATTBFAbattis Bioceuticals 0.00N/AN/AN/AFFNTF4Front Ventures 0.00N/AN/AN/AQBIOQ Biomed 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABCZFAbcamN/AN/AN/AN/AN/AN/AATTBFAbattis BioceuticalsN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AQBIOQ BiomedN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABCZFAbcamN/AC$0.17130.73N/AN/AN/AN/AN/AN/AATTBFAbattis BioceuticalsN/A-$0.16N/AN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AN/AN/AN/AQBIOQ BiomedN/A-$0.02N/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABCZFAbcamC$0.070.32%N/A42.48%N/AATTBFAbattis BioceuticalsN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AQBIOQ BiomedN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABCZFAbcam43.58%ATTBFAbattis Bioceuticals32.45%FFNTF4Front VenturesN/AQBIOQ BiomedN/AInsider OwnershipCompanyInsider OwnershipABCZFAbcamN/AATTBFAbattis BioceuticalsN/AFFNTF4Front VenturesN/AQBIOQ Biomed28.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABCZFAbcam1,750N/AN/ANot OptionableATTBFAbattis BioceuticalsN/AN/AN/ANot OptionableFFNTF4Front Ventures460N/AN/ANot OptionableQBIOQ Biomed3N/AN/ANot OptionableQBIO, FFNTF, ATTBF, and ABCZF HeadlinesRecent News About These CompaniesQ BioMed Announces Legal Settlement and Acquisition of FDA Approved Non-Opioid Metastatic Cancer Pain DrugJuly 4, 2026 | nasdaq.comQ BioMed Faces Critical Regulatory Challenge to Maintain Stock ListingMarch 6, 2026 | aktiencheck.deAQ Biomed (OTCMKTS:QBIO) & GoodRx (NASDAQ:GDRX) Financial SurveyJanuary 3, 2026 | defenseworld.netDQ BioMed IncApril 8, 2025 | uk.investing.comOrchestra Biomed Reports Q3 2024 Financial ResultsNovember 14, 2024 | markets.businessinsider.comOrchestra BioMed Reports Q3 2024 Results, Advances Key Clinical ProgramsNovember 14, 2024 | msn.comIBM's newest 156-qubit quantum chip can run 50 times faster than its predecessor — equipping it for scientific researchNovember 14, 2024 | msn.comFormer Bigfoot Biomedical CEO takes corner office at AI medtech company Q-BioOctober 11, 2024 | massdevice.comA Powerful New Tool for Biomedical ResearchSeptember 12, 2024 | msn.comOpinion: Artificial intelligence already improving biomedical research, health careSeptember 5, 2024 | sandiegouniontribune.comSClearmind Biomedical wins FDA clearance for Neuroblade minimally invasive neuroendoscopy techAugust 27, 2024 | massdevice.comMayo Clinic taps startup SandboxAQ to study new tech — quantum sensing and AI — for cardiac diagnosticsAugust 8, 2024 | fiercehealthcare.comF18th Annual Q-Bio Conference: Global scholars explore new Frontiers in quantitative biologyAugust 7, 2024 | eurekalert.orgEE&Q Master Cordless Gutta Percha Obturator from Meta BioMedMarch 24, 2024 | news-medical.netNClearside Biomedical Q4 2023 Earnings PreviewMarch 11, 2024 | msn.comQ BioMed Stock (OTC:QBIO) Dividends: History, Yield and DatesFebruary 24, 2024 | benzinga.comBiogen Inc. (BIIB) Lags Q4 Earnings and Revenue EstimatesFebruary 13, 2024 | msn.comBioxyne’s Q2 FY24 revenue surpasses $2.5m on Aussie medicinal cannabis growthJanuary 28, 2024 | msn.comQ BioMed Inc QBIONovember 16, 2023 | morningstar.comMBiomedical Sciences PhD ProgramNovember 13, 2023 | uwyo.eduUNew MarketBeat Followers Over TimeQBIO, FFNTF, ATTBF, and ABCZF Company DescriptionsAbcam OTCMKTS:ABCZFC$22.25 0.00 (0.00%) As of 07/13/2026Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. Abcam Limited was formerly known as Abcam plc and changed its name to Abcam Limited in December 2023. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam Limited operates as a subsidiary of Danaher Corporation.Abattis Bioceuticals OTCMKTS:ATTBFAbattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.4Front Ventures OTCMKTS:FFNTF4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.Q Biomed OTCMKTS:QBIOQ BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Revving Up Returns: Big Banks Race Through the Rate Plateau Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase Japan’s Crypto Overhaul Could Open the Door to a Wave of Institutional Money AI’s Power Crunch Fuels a Pivot for These 2 Oilfield Stocks PayPal Stock Surges on $53 Billion Stripe-Advent Buyout Bid Toast’s Comeback Story Is Getting Harder for Wall Street to Ignore Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
